Rafael
Falcon Moya
Investigador en el periodo 2018-2022
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (2)
2020
-
Parkin-mediated mitophagy and autophagy flux disruption in cellular models of MERRF syndrome
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 6
2019
-
Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome
Neurobiology of Disease, Vol. 125, pp. 92-106